These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16036096)

  • 21. Premenopausal women and low bone density.
    Khan A
    Can Fam Physician; 2006 Jun; 52(6):743-7. PubMed ID: 16812966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low bone mineral density in premenopausal women.
    Lewiecki EM
    South Med J; 2004 Jun; 97(6):544-50. PubMed ID: 15255419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACOG releases guidelines for clinical management of osteoporosis.
    Neff MJ;
    Am Fam Physician; 2004 Mar; 69(6):1558, 1560. PubMed ID: 15053420
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical considerations in premenopausal osteoporosis.
    Gourlay ML; Brown SA
    Arch Intern Med; 2004 Mar; 164(6):603-14. PubMed ID: 15037488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone densitometry in premenopausal women: synthesis and review.
    Khan AA; Syed Z
    J Clin Densitom; 2004; 7(1):85-92. PubMed ID: 14742892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children.
    Khan AA; Bachrach L; Brown JP; Hanley DA; Josse RG; Kendler DL; Leib ES; Lentle BC; Leslie WD; Lewiecki EM; Miller PD; Nicholson RL; O'Brien C; Olszynski WP; Theriault MY; Watts NB;
    J Clin Densitom; 2004; 7(1):51-64. PubMed ID: 14742888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications and reporting for dual-energy x-ray absorptiometry.
    Writing Group for the ISCD Position Development Conference
    J Clin Densitom; 2004; 7(1):37-44. PubMed ID: 14742886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of osteoporosis in men, premenopausal women, and children.
    Writing Group for the ISCD Position Development Conference
    J Clin Densitom; 2004; 7(1):17-26. PubMed ID: 14742884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Position statement : executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference.
    Writing Group for the ISCD Position Development Conference
    J Clin Densitom; 2004; 7(1):7-12. PubMed ID: 14742882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference curve of bone ultrasound measurements in proximal phalanges in normal Spanish women.
    Pedrera Zamorano JD; Canal Macías ML; Lavado García JM; Costa Fernández C; Borrella Domínguez S; Rico Lenza H
    J Clin Densitom; 2003; 6(4):373-80. PubMed ID: 14716051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases.
    Nakayamada S; Okada Y; Saito K; Tanaka Y
    J Rheumatol; 2004 Jan; 31(1):163-6. PubMed ID: 14705236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practice guidelines on the use of bone mineral density measurements: Who to test? What measures to use? When to treat? A consensus report from the Middle East Densitometry Workshop.
    El-Hajj Fuleihan G; Baddoura R; Awada H; Okais J; Rizk P; McClung M;
    J Med Liban; 2002; 50(3):89-104. PubMed ID: 14640175
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism.
    Rauch F; Plotkin H; Travers R; Zeitlin L; Glorieux FH
    J Clin Endocrinol Metab; 2003 Mar; 88(3):986-92. PubMed ID: 12629073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Does exercise improve the skeleton of young women?].
    Torstveit MK
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2112-5. PubMed ID: 12555648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference in the effects of body composition on bone mineral density between pre- and postmenopausal women.
    Ijuin M; Douchi T; Matsuo T; Yamamoto S; Uto H; Nagata Y
    Maturitas; 2002 Dec; 43(4):239-44. PubMed ID: 12468131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism.
    Palomba S; Orio F; Morelli M; Russo T; Pellicano M; Nappi C; Mastrantonio P; Lombardi G; Colao A; Zullo F
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4476-81. PubMed ID: 12364422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for osteoporosis in postmenopausal women: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Sep; 137(6):526-8. PubMed ID: 12230355
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women.
    Peris P; Guañabens N; Martínez de Osaba MJ; Monegal A; Alvarez L; Pons F; Ros I; Cerdá D; Muñoz-Gómez J
    Semin Arthritis Rheum; 2002 Aug; 32(1):64-70. PubMed ID: 12219322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women.
    Bainbridge KE; Sowers MF; Crutchfield M; Lin X; Jannausch M; Harlow SD
    Am J Epidemiol; 2002 Sep; 156(5):410-7. PubMed ID: 12196310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.